相关实验视频

Updated: Jun 18, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

在患有帕金森病的患者中,便胆酸与莱沃多巴反应之间的关联

Xiaoqin He¹, Yiqiu Lai¹, Chengjun Mo¹

¹Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

|July 27, 2024

概括

这项研究发现肠道胆酸与帕金森病患者对利沃多巴治疗的反应之间没有显著的联系. 需要使用先进方法进行进一步的研究来探索这种复杂的关系.

科学领域:

神经科学是一个神经科学.
胃肠病学胃肠病学
药理学药理学是指药理学的学科.

背景情况:

利沃多巴是帕金森病 (PD) 的首要治疗方法,但患者的反应有很大差异.
胆汁酸 (BAs) 越来越多地与PD病原和药物生物可用性有关.
在PD患者中,BA和Levodopa响应 (LR) 之间的关系仍然未被探索.

研究的目的:

为了研究便胆酸与帕金森病患者的勒沃多巴反应之间的关联.
为了确定特定的胆酸特征是否与不同程度的乐伏多巴疗效相关.

主要方法:

在92名PD患者中进行了Levodopa挑战测试 (LCT),以评估LR.
使用LC-MS/MS量化36个便BA和血levodopa度.
在来自患有明显LR的患者的便样本上进行了元基因组猎枪分析.

主要成果:

大多数便BA和LR之间没有发现显著的相关性,除了小的例外,为陈诺德氧胆酸-3-β-D-葡萄化物 (CDCA-3-β-葡萄化物).
在患有最低和最高LR的患者子组之间,没有观察到总体BA概况的显著差异.
两组之间没有检测到与BA代谢或编码BA酶的基因相关的肠道微生物组成的显著变化.

结论:

目前的数据不支持便胆酸与帕金森病中levodopa反应之间的直接关联.
需要更复杂的宏观代谢方法来阐明潜在的肠道微生物相互作用,影响勒沃多巴治疗效果.

关键词:

帕金森病是帕金森氏症的一种疾病.胆汁酸胆汁酸胆汁酸我们的肠道微生物组.莱沃多巴的反应反应

更多相关视频

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.